InMed Pharmaceuticals (INM) Treasury Shares: 2023-2025
Historic Treasury Shares for InMed Pharmaceuticals (INM) over the last 3 years, with Sep 2025 value amounting to $3.9 million.
- InMed Pharmaceuticals' Treasury Shares rose 673.00% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 673.00%. This contributed to the annual value of $4.5 million for FY2025, which is 734.35% up from last year.
- Per InMed Pharmaceuticals' latest filing, its Treasury Shares stood at $3.9 million for Q3 2025, which was down 13.26% from $4.5 million recorded in Q2 2025.
- Over the past 5 years, InMed Pharmaceuticals' Treasury Shares peaked at $13.2 million during Q1 2024, and registered a low of $42,096 during Q1 2025.
- For the 3-year period, InMed Pharmaceuticals' Treasury Shares averaged around $2.6 million, with its median value being $544,280 (2024).
- Data for InMed Pharmaceuticals' Treasury Shares shows a peak YoY increase of 734.35% (in 2025) and a maximum YoY decrease of 99.68% (in 2025) over the last 5 years.
- Over the past 3 years, InMed Pharmaceuticals' Treasury Shares (MRQ) stood at $559,267 in 2023, then tumbled by 91.56% to $47,176 in 2024, then surged by 8,250.03% to $3.9 million in 2025.
- Its last three reported values are $3.9 million in Q3 2025, $4.5 million for Q2 2025, and $42,096 during Q1 2025.